Defective ST3GAL3 does not transfer SA to keratan

Stable Identifier
R-HSA-3656258
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Golgi membrane, Golgi lumen
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective ST3GAL3 does not transfer SA to keratan
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (ST3GAL3) mediates the transfer of sialic acid from CMP-sialic acid to galactose-containing glycoproteins and forms the sialyl Lewis, an epitope on proteins which are required for attaining and/or maintaining higher cognitive functions. Some defects in ST3GAL3 result in mental retardation, autosomal recessive 12 (MRT12; MIM:611090), a disorder characterised by below average general intellectual function and impaired adaptative behaviour. Another defect of ST3GAL3 can cause early infantile epileptic encephalopathy-15 (EIEE15: MIM:615006), resulting in severe mental retardation.

In two ST3GAL3 homozygous mutations causing MRT12, A13D and D370Y, most of the mutant protein was improperly localized to the endoplasmic reticulum. This prevented the protein from interacting with its substrates in the Golgi, resulting in a loss of function and loss of the sialyl Lewis, an epitope important for higher cognative functions (Najmabadi et al. 2007, Hu et al. 2011). Another homozygous mutation, A320P, causing EIEE15, functional expression studies showed a 75% reduction in the secretion of the mutant protein and no detectable enzymatic activity (Edvardson et al. 2012). This mutation affects the highly conserved sialyl motif S, which is crucial for binding both donor and acceptor substrates.
Literature References
PubMed ID Title Journal Year
21907012 ST3GAL3 mutations impair the development of higher cognitive functions

Hucho, T, Wrogemann, K, Garshasbi, M, Mühlenhoff, M, Hosseini, M, Gerardy-Schahn, R, Eggers, K, Motazacker, MM, Kuss, AW, Kahrizi, K, Chen, W, Hu, H, Tzschach, A, Ropers, HH, Bahman, I, Najmabadi, H

Am. J. Hum. Genet. 2011
23252400 West syndrome caused by ST3Gal-III deficiency

Kuss, AW, Elpeleg, O, Shaag, A, Mühlenhoff, M, Zenvirt, S, Stephan, O, Gerardy-Schahn, R, He, L, Baumann, AM, Tanzi, R, Edvardson, S

Epilepsia 2013
17120046 Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci

Behjati, F, Seifati, SM, Garshasbi, M, Hadavi, V, Abedini, SS, Falah, M, Kuss, AW, Chen, W, Kahrizi, K, Lenzner, S, Vazifehmand, R, Grüters, A, Firouzabadi, SG, Jensen, LR, Tzschach, A, Jamali, P, Ropers, HH, Najmabadi, H, Motazacker, MM, Nieh, SE, Rüschendorf, F

Hum. Genet. 2007
Participants
Input
Participates
as an event of
Catalyst Activity

beta-galactoside (CMP) alpha-2,3-sialyltransferase activity of ST3GAL3 mutants [Golgi membrane]

Physical Entity
ST3GAL3 mutants [Golgi membrane] (Homo sapiens)
Activity
beta-galactoside (CMP) alpha-2,3-sialyltransferase activity (GO:0003836)
Normal reaction
The keratan chain can be capped by N-acetylneuraminic acid (Homo sapiens)
Functional status

Loss of function of ST3GAL3 mutants [Golgi membrane]

Normal Entity
Disease Entity
Status
Disease
Authored
Jassal, B  (2013-05-31)
Reviewed
Spillmann, D  (2014-07-09)
Created
Jassal, B  (2013-05-31)
Cite Us!